MR-Guided Transurethral Ultrasound Ablation (TULSA)—An Emerging Minimally Invasive Treatment Option for Localised Prostate Cancer.

MLA

Fung, Kin Fen Kevin, et al. “MR-Guided Transurethral Ultrasound Ablation (TULSA)—An Emerging Minimally Invasive Treatment Option for Localised Prostate Cancer.” CardioVascular & Interventional Radiology, vol. 47, no. 6, June 2024, pp. 689–701. EBSCOhost, https://doi.org/10.1007/s00270-024-03696-y.

APA

Fung, K. F. K., Cazzato, R. L., Tricard, T., Marini, P. D. E., Bertucci, G., Autrusseau, P.-A., Koch, G., Weiss, J., Garnon, J., Lang, H., & Gangi, A. (2024). MR-Guided Transurethral Ultrasound Ablation (TULSA)—An Emerging Minimally Invasive Treatment Option for Localised Prostate Cancer. CardioVascular & Interventional Radiology, 47(6), 689–701. https://doi.org/10.1007/s00270-024-03696-y

Chicago

Fung, Kin Fen Kevin, Roberto Luigi Cazzato, Thibault Tricard, Pierre D. E. Marini, Gregory Bertucci, Pierre-Alexis Autrusseau, Guillaume Koch, et al. 2024. “MR-Guided Transurethral Ultrasound Ablation (TULSA)—An Emerging Minimally Invasive Treatment Option for Localised Prostate Cancer.” CardioVascular & Interventional Radiology 47 (6): 689–701. doi:10.1007/s00270-024-03696-y.